N. SOYER Et Al. , "Retrospective and multicenter analysis of efficacy and safety of ruxolitinib in 176 Turkish patients with myelofibrosis: updated data," IXth International Eurasian Hematology Oncology Congress , vol.73, İstanbul, Turkey, pp.46, 2018
SOYER, N. Et Al. 2018. Retrospective and multicenter analysis of efficacy and safety of ruxolitinib in 176 Turkish patients with myelofibrosis: updated data. IXth International Eurasian Hematology Oncology Congress , (İstanbul, Turkey), 46.
SOYER, N., ALİ, R., HAZNEDAROĞLU, İ. C., YILMAZ, F., AYDOĞDU, İ., PİR, A., ... KARAKUŞ, V.(2018). Retrospective and multicenter analysis of efficacy and safety of ruxolitinib in 176 Turkish patients with myelofibrosis: updated data . IXth International Eurasian Hematology Oncology Congress (pp.46). İstanbul, Turkey
SOYER, NUR Et Al. "Retrospective and multicenter analysis of efficacy and safety of ruxolitinib in 176 Turkish patients with myelofibrosis: updated data," IXth International Eurasian Hematology Oncology Congress, İstanbul, Turkey, 2018
SOYER, NUR Et Al. "Retrospective and multicenter analysis of efficacy and safety of ruxolitinib in 176 Turkish patients with myelofibrosis: updated data." IXth International Eurasian Hematology Oncology Congress , İstanbul, Turkey, pp.46, 2018
SOYER, N. Et Al. (2018) . "Retrospective and multicenter analysis of efficacy and safety of ruxolitinib in 176 Turkish patients with myelofibrosis: updated data." IXth International Eurasian Hematology Oncology Congress , İstanbul, Turkey, p.46.
@conferencepaper{conferencepaper, author={NUR SOYER Et Al. }, title={Retrospective and multicenter analysis of efficacy and safety of ruxolitinib in 176 Turkish patients with myelofibrosis: updated data}, congress name={IXth International Eurasian Hematology Oncology Congress}, city={İstanbul}, country={Turkey}, year={2018}, pages={46} }